ENGEDI RX
↗Roswell, Georgia, USA
ENGEDI RX is a pharmacy benefit solutions provider that specializes in reducing prescription drug costs for self-insured employers, brokers, and health plan members. The company positions itself as a transparent alternative to traditional Pharmacy Benefit Managers (PBMs), claiming to reduce pharmacy spend by 40-60% through data-driven strategies and alternative sourcing methods.
The company's service suite includes formulary management, utilization management, and specialized programs for high-cost specialty drugs. By integrating with existing health benefits, ENGEDI RX aims to bridge the gap between rising medication costs and affordability, utilizing tools such as personal importation for specialty medications and direct-to-member support to ensure adherence and cost-effectiveness.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2022
Ownership:private
Status:operating
FUNDING
Stage:Seed
PIPELINE
Stage:Commercial
Lead Drug Stage:Not applicable (Service Provider)
Modalities:Small molecule, Biologics, Specialty Medications
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:En Gedi Reserve (Program/Service)
Key Partnerships:Self-insured employers, Employee benefit brokers, Specialty pharmacies
COMPETITION
Position:Niche Player
Competitors:CVS Caremark, Express Scripts, OptumRx, Navitus Health Solutions, Capital Rx, SmithRx
LEADERSHIP
Key Executives:
Alan Greensmith - Managing Director
LINKS
Website:engedirx.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with ENGEDI RX. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.